Nisa Investment Advisors LLC Decreases Position in Option Care Health, Inc. (NASDAQ:OPCH)

Nisa Investment Advisors LLC decreased its position in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 88.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,703 shares of the company’s stock after selling 12,823 shares during the quarter. Nisa Investment Advisors LLC’s holdings in Option Care Health were worth $40,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors and hedge funds also recently made changes to their positions in the company. FMR LLC increased its holdings in Option Care Health by 134.0% in the 3rd quarter. FMR LLC now owns 7,516,448 shares of the company’s stock worth $235,265,000 after buying an additional 4,304,896 shares in the last quarter. Victory Capital Management Inc. boosted its holdings in shares of Option Care Health by 4,432.8% during the 3rd quarter. Victory Capital Management Inc. now owns 1,621,593 shares of the company’s stock valued at $50,756,000 after acquiring an additional 1,585,818 shares during the last quarter. Wellington Management Group LLP boosted its holdings in shares of Option Care Health by 15.5% during the 3rd quarter. Wellington Management Group LLP now owns 9,924,915 shares of the company’s stock valued at $310,650,000 after acquiring an additional 1,328,326 shares during the last quarter. Geneva Capital Management LLC bought a new stake in shares of Option Care Health in the third quarter worth approximately $24,679,000. Finally, Westfield Capital Management Co. LP raised its holdings in shares of Option Care Health by 10.2% during the third quarter. Westfield Capital Management Co. LP now owns 6,492,152 shares of the company’s stock valued at $203,204,000 after purchasing an additional 599,589 shares during the last quarter. Institutional investors own 98.05% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on the stock. Barrington Research raised their target price on shares of Option Care Health from $32.00 to $33.00 and gave the stock an “outperform” rating in a report on Tuesday, January 14th. JMP Securities restated a “market outperform” rating and issued a $30.00 price target (down from $31.00) on shares of Option Care Health in a research note on Friday, January 10th. Truist Financial reduced their price objective on Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a research report on Friday, November 1st. Bank of America raised Option Care Health from a “neutral” rating to a “buy” rating and increased their target price for the company from $26.00 to $33.00 in a report on Monday, January 13th. Finally, The Goldman Sachs Group downgraded Option Care Health from a “buy” rating to a “neutral” rating and cut their price target for the company from $38.00 to $27.00 in a research note on Monday, November 4th. Two equities research analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $32.25.

Option Care Health Price Performance

NASDAQ OPCH opened at $30.92 on Friday. The business’s fifty day moving average is $25.16 and its 200 day moving average is $27.91. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $34.63. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The company has a market capitalization of $5.26 billion, a PE ratio of 25.98, a price-to-earnings-growth ratio of 2.20 and a beta of 1.31.

Insider Transactions at Option Care Health

In other news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of Option Care Health stock in a transaction dated Friday, November 8th. The stock was purchased at an average cost of $22.54 per share, with a total value of $969,220.00. Following the completion of the purchase, the director now directly owns 326,334 shares in the company, valued at approximately $7,355,568.36. This trade represents a 15.18 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Corporate insiders own 0.64% of the company’s stock.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.